Vasi Sperry

  • Citations Per Year
Learn More
OBJECTIVE Vilazodone is a potent serotonin reuptake inhibitor and 5-HT1A receptor partial agonist approved for the treatment of major depressive disorder (MDD) in adults. The effect of clinical and supratherapeutic doses of vilazodone on cardiac repolarization was determined in healthy volunteers. METHODS In this Phase 1, randomized, doubleblind, placebo-(More)
  • 1